Headlines
يكشنبه, 14 شهريور 1389 


 
Yazd Biotechnology Incubator

> گروه اخبار > Miscellaneous > مشروح خبر _PRINTER_FRIENDLY


Enigma Diagnostics appoints Professor Christopher Lowe as non-executive director
نگارنده خبر: پشتیبانی گروه دیبا
تاریخ ثبت: 1385/10/22

22 Dec 2006 - Enigma Diagnostics, a life sciences company developing rapid molecular diagnostics systems, announced the appointment of Professor Christopher Lowe as Non-executive Director.Professor Lowe is Director of the Institute of Biotechnology at the University of Cambridge. He is a Fellow of the Royal Academy of Engineering, the Institute of Physics and the Royal Society of Chemistry.  
 
Over the past 30 years, Prof. Lowe has focused on the development of pharmaceuticals, fine chemicals and diagnostics based on a highly inter- and multi-disciplinary approach. His approach combines aspects of biochemistry, microbiology, chemistry, electrochemistry, physics, electronics, medicine and chemical engineering, and from pure science to strategic applied science to the development of commercial applications.

تعداد مطالعه 2207 مرتبه بوده است.

عناوين مرتبط
Prophylactic Staphylococcus aureus subunit vaccine shows promising results
Innogenetics extends its diagnostics product portfolio for Alzheimer's disease with new products
Enigma Diagnostics appoints Professor Christopher Lowe as non-executive director
Challenges and Opportunities in the Global Protein Therapeutics Market
Organon's insomnia compound Org 50081 moves into phase III clinical trials
  نظر بدهيد:
* نام:  
* ايميل:  
* متن:
محدوديت تايپ: حرف
* كد امنيتي:   <